Koch, S., Knipfer, L., Kölle, J., Mirzakhani, H., Graser, A., Zimmermann, T., . . . Finotto, S. (2019). Targeted deletion of NFAT-Interacting-Protein-(NIP) 45 resolves experimental asthma by inhibiting Innate Lymphoid Cells group 2 (ILC2). Friedrich-Alexander-Universität Erlangen-Nürnberg.
Chicago-Zitierstil (17. Ausg.)Koch, Sonja, et al. Targeted Deletion of NFAT-Interacting-Protein-(NIP) 45 Resolves Experimental Asthma by Inhibiting Innate Lymphoid Cells Group 2 (ILC2). Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2019.
MLA-Zitierstil (9. Ausg.)Koch, Sonja, et al. Targeted Deletion of NFAT-Interacting-Protein-(NIP) 45 Resolves Experimental Asthma by Inhibiting Innate Lymphoid Cells Group 2 (ILC2). Friedrich-Alexander-Universität Erlangen-Nürnberg, 2019.